News
Help Brittany and Emily beat Stage IV RET-posit...
June is RET Awareness Month! In 2022, RETpositive helped raise $2.2 million for RET research and is again partnering with Lungevity to fund another round of critical RET research projects...
Help Brittany and Emily beat Stage IV RET-posit...
June is RET Awareness Month! In 2022, RETpositive helped raise $2.2 million for RET research and is again partnering with Lungevity to fund another round of critical RET research projects...
RETpositive and The White Ribbon Project Co-hos...
Would you like to join or co-host a white ribbon build? RETpositive is joining with The White Ribbon Project to co-host a series of in-person white ribbon builds throughout RET Awareness Month in...
RETpositive and The White Ribbon Project Co-hos...
Would you like to join or co-host a white ribbon build? RETpositive is joining with The White Ribbon Project to co-host a series of in-person white ribbon builds throughout RET Awareness Month in...
Andrea Redway, RET Patient, Co-Authors ICI Case...
Dr. Garth Nicholas, University of Ottawa oncologist, has co-authored a case report with our very own Andrea Redway, Stage 4 RET+ non-small cell lung cancer (NSCLC) patient who successfully responded to immune...
Andrea Redway, RET Patient, Co-Authors ICI Case...
Dr. Garth Nicholas, University of Ottawa oncologist, has co-authored a case report with our very own Andrea Redway, Stage 4 RET+ non-small cell lung cancer (NSCLC) patient who successfully responded to immune...
RET Patients, Caregivers Connect with Reuben Re...
Recently, several RET patients connected over Zoom with Dr. Alexandre Reuben and his research associates at the Reuben Lab at MD Anderson Cancer Center. Each survivor shared their health journey with the lab team,...
RET Patients, Caregivers Connect with Reuben Re...
Recently, several RET patients connected over Zoom with Dr. Alexandre Reuben and his research associates at the Reuben Lab at MD Anderson Cancer Center. Each survivor shared their health journey with the lab team,...
Gavreto and Retevmo Co-pay Assistance Programs
Gavreto (pralsetinib) and Retevmo (selpercatinib) are prescription medications used to treat RET-positive cancer. Both the medications have their own Co-pay Assistance Programs which are designed to help eligible patients with...
Gavreto and Retevmo Co-pay Assistance Programs
Gavreto (pralsetinib) and Retevmo (selpercatinib) are prescription medications used to treat RET-positive cancer. Both the medications have their own Co-pay Assistance Programs which are designed to help eligible patients with...
RETexperts - oncologists specializing in RET fu...
The following is a list of RET experts with experience in care for many RET+ patients and who are actively involved in the latest RET related research. As a benefit...
RETexperts - oncologists specializing in RET fu...
The following is a list of RET experts with experience in care for many RET+ patients and who are actively involved in the latest RET related research. As a benefit...